日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study

瑞维替尼治疗伴有中枢神经系统转移的EGFR突变型非小细胞肺癌患者:来自III期REZOR研究的中枢神经系统疗效

Yang, Sheng; Zhao, Yanqiu; Sun, Meili; Bi, Minghong; Zhu, Bo; Chen, Zhaohong; Yu, Huiqing; Zhang, Liangming; Wu, Lin; Zhou, Rui; Yao, Wenxiu; Li, Xingya; Han, Zhigang; Wang, Ke; Wang, Lijun; Wen, Meiling; Guo, Yanzhen; Lin, Yingcheng; Sun, Shenghua; Guo, Shuliang; Yi, Tienan; Zhao, Wenhua; Yu, Zhuang; Qin, Jianwen; Pan, Yueyin; He, Zhiyong; Ye, Feng; Shi, Huaqiu; Fang, Jian; Ma, Rui; Lu, Hong; Zhang, Hua; Shi, Jianhua; Gao, Jinghua; Cui, Jiuwei; Li, Manxiang; Yi, Shanyong; Cang, Shundong; Shu, Yongqian; Zhang, Don; Peng, Jirong; Gao, Feng; Wang, Tingting; Zhou, Anqi; Shi, Yuankai

Illuminating Mitochondrial RNA G-Quadruplexes as Structural Brakes on RNA Granule Assembly and OXPHOS

揭示线粒体RNA G-四链体作为RNA颗粒组装和氧化磷酸化的结构刹车

Tang, Gui-Xue; Yan, Jia-Tong; Li, Mao-Lin; Zhou, Cui; Wang, Jian; Chen, Shuo-Bin; Huang, Zhi-Shu; Tan, Jia-Heng

Systemic CSF1R Targeting Depletes Pathogenic MPS Bubs and Ameliorates Psoriasis via PPARα-mediated Resolution.

系统性 CSF1R 靶向治疗可清除致病性 MPS 芽体,并通过 PPARα 介导的消退作用改善银屑病。

Lin Zhen-Jia, Li Ying, Yu Yangyinhui, Fang Mei-Jia, Xiong Ying, Xu Rui, Wang Zhuo, Zhang Jun, Xu Ya-Nan, Wan Jun-Ya, Ji Xiang, Zheng Yu-Fan, Zhang Kai-Lang, Wei Ming, Zou Jun-Tao, Jia Li-Xuan, Zhang Hui, Li Chang-Lin, Zhou Li-Jun, Tan Zhi

ZOVER 2.0: a virome-based platform for zoonotic and vector-borne viruses

ZOVER 2.0:一个基于病毒组的动物源性和媒介传播病毒平台

Liu, Bo; Zhu, Lin; Zhou, Siyu; Li, Aiyun; Xu, Panpan; Han, Yelin; Shu, Yuelong; Chen, Lihong; Yang, Jian; Wu, Zhiqiang

Gastrointestinal traits, common inflammatory disorders, gallstones, and biliary tract cancer: A network Mendelian randomization study

胃肠道特征、常见炎症性疾病、胆结石和胆道癌:一项网络孟德尔随机化研究

Bai, Ye; Zhang, Min; Chen, Lin; Zhou, Peiwen; Zhou, Bai; Wang, Ruobing; Li, Rixin; Si, Junzhuo; Zhou, Shuai; Jiang, Yanfang

Integrative multi-omics profiling deciphers tumor microenvironment heterogeneity and immunotherapy vulnerabilities in lung neuroendocrine carcinomas

整合多组学分析揭示肺神经内分泌癌的肿瘤微环境异质性和免疫治疗脆弱性

Zhang, Zicheng; Zhai, Modi; Bao, Siqi; Sun, Xujie; Chen, Ruanqi; Wang, Bingning; Yang, Fan; Yang, Lin; Zhou, Meng

Multidimensional mapping of stimulation-responsive regulatory elements and candidate causal variants in T cell activation.

T 细胞活化中刺激反应调控元件和候选致病变异的多维映射。

Wang Zhao, Dong Wei, Feng Xiangling, Xu Xinran, An Yao, Xiao Huiling, Luo Menghan, Liang Qian, Bai Ruoxuan, Zhao Ke, Wu Liuxing, Zhao Lin, Zhou Yao, Yi Xianfu, Huang Dandan, Sengupta Kaustav, Plewczynski Dariusz, Sham Pak Chung, Liu Chao, Yu Yang, Li Wei, Gong Qing, Song Weihong, Zhou Wenhao, Li Mulin Jun

Clinical application of PARP inhibitors and emerging strategies to overcome resistance: a pan-cancer perspective

PARP抑制剂的临床应用及克服耐药性的新兴策略:泛癌视角

Xiang, Jiahui; Li, Jiayi; Guo, Zizhao; Wu, Jiang; Ma, Dongxu; Xu, Hengyi; Shang, Tongxuan; Pu, Pengming; Cong, Lin; Zhou, Ruijie; Wang, Xiang; Yu, Yingjie; Liu, Jiaqi

Discovery of a First-in-Class Murine Double Minute 2-Recruiting Positive Transcription Elongation Factor B PROTAC Degrader With Selective Antitumor Activity.

发现一种具有选择性抗肿瘤活性的首创鼠源双微体 2 募集正转录延伸因子 B PROTAC 降解剂。

Guan Xian, Xie Long, Guo Hanjun, Ma Lin, Zhou Jiawei, Luo Lisong, Yang Hao, Wu Yuanfang, Liu Jiangyu, Wang Yue, Huang Xingze, Liu Jiyang, Zhang Ying, Chen Wenhao, Chen Ye, Xu Liang, Han Xin

Validation of a clinical scoring model and proposal of a classification system to guide endoscopic resection strategies for cardial submucosal tumors

验证临床评分模型并提出分类系统以指导贲门黏膜下肿瘤的内镜切除策略

Geng, Zi-Han; Wan, Min-Yue; He, Meng-Jiang; Fu, Pei-Yao; Zhu, Yan; Li, Zhuang-Zhuang; Huang, Lin; Jiang, Zhi-Bin; Chen, Jin-Ning; Liu, Yao-Gang; Ding, Hui-Bin; Ye, Ying-Jian; Wang, Zhe; Nie, Lin; Li, Quan-Lin; Zhou, Ping-Hong; Liu, Jing-Zheng